neuroendocrine tumors

World Neuroendocrine Tumor Awareness Day (NET Cancer Day) will be observed on Wednesday, Nov. 10, which makes this a good time to learn more about [...]

Diagnosed with a rare neuroendocrine tumor while she was pregnant, Dr. Staci Tanouye and her husband, Dr. Amit Merchea, turned to a team of Mayo Clinic specialists to safeguard Dr. Tanouye's health and that of their baby. Under that expert care, their son was safely delivered and the tumor successfully removed.

For some patients neuroendocrine tumors lead to diarrhea or pain, while others will have no symptoms and the tumors are only discovered during an [...]

Neuroendocrine tumors Neuroendocrine tumors are rare and can occur anywhere in the body. Most neuroendocrine [...]

Whipple procedure: An overview  A Whipple procedure, also known as a pancreaticoduodenectomy, is a complex operation to remove the head of [...]

Hormone therapy for prostate cancer  Most prostate cancer cells rely on testosterone to help them grow. Hormone therapy for prostate cancer, also called androgen [...]

Making the tough choice on cancer treatment A new diagnosis of cancer is incredibly stressful, and this stress can make it even [...]

Researchers at Mayo Clinic have completed the world’s first whole exome sequence of small intestine neuroendocrine tumors, also known to patients and physicians as carcinoids, the most common cancer of the small bowel and one that responds poorly to chemotherapy. Mayo oncologist and lead author Michaela Banck, M.D., says, “This is a very important step in achieving targeted therapies and individualized treatment approaches for patients with small bowel carcinoids. Genomic analysis of the individual patient’s tumors will help us identify new drugs that are targeted to the individual’s disease.” Click here for news release